RPTX - Repare Therapeutics Inc. -  [ ]

Ticker Details
Repare Therapeutics Inc.
IPO Date: May 2, 2022
Sector: Healthcare
Industry: Biotech
Market Cap: $114.24M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.41 | 3.06%
Avg Daily Range (30 D): $0.02 | 0.74%
Avg Daily Range (90 D): $0.03 | 1.68%
Institutional Daily Volume
Avg Daily Volume: .24M
Avg Daily Volume (30 D): .36M
Avg Daily Volume (90 D): .73M
Trade Size
Avg Trade Size (Sh.): 131
Avg Trade Size (Sh.) (30 D): 533
Avg Trade Size (Sh.) (90 D): 332
Institutional Trades
Total Institutional Trades: 60
Avg Institutional Trade: $1.66M
Avg Institutional Trade (30 D): $4.15M
Avg Institutional Trade (90 D): $2.2M
Avg Institutional Trade Volume: .26M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.49M
Avg Closing Trade (30 D): $2.61M
Avg Closing Trade (90 D): $2.61M
Avg Closing Volume: 162.82K
 
News
Dec 24, 2025 @ 1:36 PM
Repare Therapeutics Stock Rises As Gilead Secures ...
Source: Vandana Singh
Dec 17, 2025 @ 9:35 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Conti...
Source: Juan Monteverde
Nov 27, 2025 @ 11:47 PM
Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareh...
Source: Halper Sadeh Llc
Nov 27, 2025 @ 10:52 PM
HAPPY THANKSGIVING AND $HAREHOLDER ALERT: The M&A ...
Source: Juan Monteverde
Nov 17, 2025 @ 3:24 PM
Repare Therapeutics Agrees To Acquisition As Board...
Source: Vandana Singh
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $.08 $-.39
Diluted EPS $.08 $-.39
Revenue $15.01M $5.92M
Gross Profit
Net Income / Loss $3.26M $-16.74M
Operating Income / Loss $1.13M $-17.78M
Cost of Revenue
Net Cash Flow $5.17M $-16.8M
PE Ratio